COVID 19 IgG ELISA
- UID
- MFG/IVD/2021/000019_fd504a975135262194e4558b5e8e248c_4b5b95b1cd609ce1d89b8d00821adfae
- Device class
- Class D
- Brand name
- Prolisa
- License holder
- Promea Therapeutics Private Limited
- Approving authority
- CDSCO, Zonal office, Hyderabad
- Product information
- Prolisa Covid-19 IgG ELISA is an in vitro enzyme immunoassay for the qualitative determination of human anti-COVID-19 IgG antibody in human serum and plasma.
COVID 19 IgG ELISA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000019_fd504a975135262194e4558b5e8e248c_4b5b95b1cd609ce1d89b8d00821adfae. This device is marketed under the brand name Prolisa. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.